137 related articles for article (PubMed ID: 6688636)
21. Sexual dimorphism in regional blood flow responses to vasopressin in conscious rats.
Wang YX; Crofton JT; Bealer SL; Share L
Am J Physiol; 1997 Sep; 273(3 Pt 2):R1126-31. PubMed ID: 9321895
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin V1-receptor blockade lowers arterial blood pressure in young conscious Long-Evans rats.
Obika LF; Laycock JF
Q J Exp Physiol; 1989 May; 74(3):371-4. PubMed ID: 2526346
[TBL] [Abstract][Full Text] [Related]
23. Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits.
Albert M; Losser MR; Hayon D; Faivre V; Payen D
Crit Care Med; 2004 Sep; 32(9):1891-8. PubMed ID: 15343018
[TBL] [Abstract][Full Text] [Related]
24. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
Feng JJ; Arendshorst WJ
Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
[TBL] [Abstract][Full Text] [Related]
25. The role of vasopressin in blood pressure regulation immediately following acute haemorrhage in the rat.
Laycock JF; Penn W; Shirley DG; Walter SJ
J Physiol; 1979 Nov; 296():267-75. PubMed ID: 529092
[TBL] [Abstract][Full Text] [Related]
26. Control of renal medullary blood flow by vasopressin V1 and V2 receptors.
Nakanishi K; Mattson DL; Gross V; Roman RJ; Cowley AW
Am J Physiol; 1995 Jul; 269(1 Pt 2):R193-200. PubMed ID: 7631893
[TBL] [Abstract][Full Text] [Related]
27. Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Jan; 102(1):65-72. PubMed ID: 2043932
[TBL] [Abstract][Full Text] [Related]
28. Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats.
Carter DA; Lightman SL
J Physiol; 1985 Oct; 367():363-75. PubMed ID: 2997441
[TBL] [Abstract][Full Text] [Related]
29. Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats.
Gellai M; Silverstein JH; Hwang JC; LaRochelle FT; Valtin H
Am J Physiol; 1984 Jun; 246(6 Pt 2):F819-27. PubMed ID: 6742157
[TBL] [Abstract][Full Text] [Related]
30. Contribution of vasopressin to the maintenance of blood pressure during dehydration.
Woods RL; Johnston CI
Am J Physiol; 1983 Nov; 245(5 Pt 1):F615-21. PubMed ID: 6356937
[TBL] [Abstract][Full Text] [Related]
31. Effect of aprotinin on the renal response to vasopressin in diabetes insipidus rats.
Fejes-Toth G; Frölich JC; Naray-Fejes-Toth A
J Physiol; 1983 Jun; 339():585-90. PubMed ID: 6193269
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of serotonin and DP-5-CT in conscious Long-Evans and Brattleboro rats.
Anderson IK; Ramage AG; Gardiner SM
Am J Physiol; 1996 Aug; 271(2 Pt 2):R455-63. PubMed ID: 8770148
[TBL] [Abstract][Full Text] [Related]
33. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
Walker LA; Frölich JC
J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation.
Aki Y; Tamaki T; Kiyomoto H; He H; Yoshida H; Iwao H; Abe Y
J Cardiovasc Pharmacol; 1994 Feb; 23(2):331-6. PubMed ID: 7511766
[TBL] [Abstract][Full Text] [Related]
35. Central effects of endothelin-1 on vasopressin release, blood pressure, and renal solute excretion.
Yamamoto T; Kimura T; Ota K; Shoji M; Inoue M; Sato K; Ohta M; Yoshinaga K
Am J Physiol; 1992 Jun; 262(6 Pt 1):E856-62. PubMed ID: 1535483
[TBL] [Abstract][Full Text] [Related]
36. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
Handa RK; Strandhoy JW; Handa SE
Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
[TBL] [Abstract][Full Text] [Related]
37. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
38. Effects of steady-state plasma vasopressin levels on the distribution of intrarenal blood flow on electrolyte excretion.
Akatsuka N; Moran WH; Morgan ML; Wilson MF
J Physiol; 1977 Apr; 266(3):567-86. PubMed ID: 864614
[TBL] [Abstract][Full Text] [Related]
39. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
László FA; Csáti S; Baláspiri L
Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
[TBL] [Abstract][Full Text] [Related]
40. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
Pucci ML; Lin L; Nasjletti A
J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
